Yahoo Finance Is Janus Henderson Global Life Science A (JFNAX) a Strong Mutual Fund Pick Right Now?
Any investors hoping to find a Sector - Health fund could think about starting with Janus Henderson Global Life Science A (JFNAX). JFNAX bears a Zacks Mutual Fund Rank of 2 (Buy), which is based on various forecasting factors like size, cost, and past performance.
Objective
The world of Sector - Health funds is an area filled with options, such as JFNAX. Healthcare is one of the biggest sectors of the American economy, and Sector - Health mutual funds provide a great opportunity to invest in this industry. Here, funds can include everything from for-profit hospitals to pharmaceutical companies and medical device manufacturers.
History of Fund/Manager
JFNAX finds itself in the Janus Fund family, based out of Boston, MA. Janus Henderson Global Life Science A made its debut in July of 2009, and since then, JFNAX has accumulated about $271.96 million in assets, per the most up-to-date date available. The fund is currently managed by Andy Acker who has been in charge of the fund since July of 2009.
Performance
Of course, investors look for strong performance in funds. This fund carries a 5-year annualized total return of 12.42%, and is in the top third among its category peers. But if you are looking for a shorter time frame, it is also worth looking at its 3-year annualized total return of 5.8%, which places it in the top third during this time-frame.
It is important to note that the product's returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund's [%] sale charge. If sales charges were included, total returns would have been lower.
When looking at a fund's performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. The standard deviation of JFNAX over the past three years is 15.52% compared to the category average of 14.66%. Looking at the past 5 years, the fund's standard deviation is 16.28% compared to the category average of 15.59%. This makes the fund more volatile than its peers over the past half-decade.
Risk Factors
Investors should note that the fund has a 5-year beta of 0.73, which means it is hypothetically less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio's performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. With a positive alpha of 0.58, managers in this portfolio are skilled in picking securities that generate better-than-benchmark returns.
Expenses
As competition heats up in the mutual fund market, costs become increasingly important. Compared to its otherwise identical counterpart, a low-cost product will be an outperformer, all other things being equal. Thus, taking a closer look at cost-related metrics is vital for investors. In terms of fees, JFNAX is a load fund. It has an expense ratio of 0.98% compared to the category average of 0.98%. Looking at the fund from a cost perspective, JFNAX is actually on par with its peers.
While the minimum initial investment for the product is $2,500, investors should also note that there is no minimum for each subsequent investment.
Fees charged by investment advisors have not been taken into considiration. Returns would be less if those were included.
Bottom Line
Overall, Janus Henderson Global Life Science A ( JFNAX ) has a high Zacks Mutual Fund rank, and in conjunction with its comparatively strong performance, average downside risk, and on par fees, Janus Henderson Global Life Science A ( JFNAX ) looks like a good potential choice for investors right now.
Don't stop here for your research on Sector - Health funds. We also have plenty more on our site in order to help you find the best possible fund for your portfolio. Make sure to check out www.zacks.com/funds/mutual-funds for more information about the world of funds, and feel free to compare JFNAX to its peers as well for additional information. If you are more of a stock investor, make sure to also check out our Zacks Rank, and our full suite of tools we have available for novice and professional investors alike.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get Your Free (JFNAX): Fund Analysis Report
